Records containing: Melanoma (Skin)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-16Phase II Study of Adjuvant Nivolumab in Patients With Resected Stage IIB/IIC Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-27Effectiveness of Group and Individual Training in Emotional Freedom Techniques for Patients in Remission From Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-22Fianlimab and Cemiplimab as Total Neoadjuvant Therapy (TNT) For Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-01Modulating Immune-Microbiome Axis Through High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
-
CLINICAL_TRIALS study record update · 2026-03-10Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-02A First-in-Human, Open-label, Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With Advanced-Stage, Relapsed/Refractory HER3-Expressing Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-05Pilot Study of Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
-
CLINICAL_TRIALS study record update · 2026-01-14Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
-
CLINICAL_TRIALS study record update · 2026-01-12A Prospective Non Interventional Study on Targeted Therapy for Patients With Unresectable or Metastatic BRAFV600E Mutant Melanoma
-
CLINICAL_TRIALS study record update · 2025-12-31Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma
-
CLINICAL_TRIALS study record update · 2025-12-31Phase II Study of Adjuvant Nivolumab in Patients With Resected Stage IIB/IIC Melanoma
-
CLINICAL_TRIALS study record update · 2025-12-19A Phase 2, Multicentre, Open-Label, Umbrella Study of SCIB1 and iSCIB1+ in Patients With Advanced Unresectable Melanoma Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)
-
CLINICAL_TRIALS study record update · 2025-12-08Phase II Dual-Cohort Study Evaluating the Effects of Pembrolizumab in the Presence of Gut Microbiota Modulation With EDP1503 in Advanced Melanoma Naïve or Refractory to Anti-PD1 Antibody
-
CLINICAL_TRIALS study record update · 2025-10-01Cryotherapy Under Interventional Radiology Combined With in Situ Ipilimumab and a Flat Dose of Nivolumab in Stage IIIB/C Melanoma. Prospective Proof of Concept Study.
-
CLINICAL_TRIALS study record update · 2025-09-19Zirconium Zr 89 Crefmirlimab Berdoxam (Anti-CD8 Minibody) PET/CT Imaging as a Measure of Response in Patients With Advanced Melanoma on Immunotherapy Plus Hydroxychloroquine.
-
CLINICAL_TRIALS study record update · 2025-09-05A Study to Evaluate the Safety and Immune Activity of PeptiCRAd-1 in Combination With Pembrolizumab in Patients With Injectable Solid Tumors in Indications Known to Express NY-ESO-1 and MAGE-A3
-
CLINICAL_TRIALS study record update · 2025-08-26A Phase 1/2 Study of ANV419 as Monotherapy or in Combination With Anti-PD-1 or Anti-CTLA-4 Antibody Following Anti-PD-1/Anti-PD-L1 Antibody Treatment in Patients With Unresectable or Metastatic Cutaneous Melanoma (OMNIA-1)
-
CLINICAL_TRIALS study record update · 2025-08-19A Pilot Clinical Trial Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2025-07-31MoleGazer: A Feasibility Study for Early Detection of Melanoma
-
CLINICAL_TRIALS study record update · 2025-07-22French National Cohort of Patients With Melanoma (Any Stage). Network for Research and Clinical Investigation, the RIC-Mel Network.
-
CLINICAL_TRIALS study record update · 2025-07-17A Phase II Non-Randomized, Open-label, Multi-centre Study of the Safety and Efficacy of Tebentafusp in Melanoma With Molecular Relapsed Disease
-
CLINICAL_TRIALS study record update · 2025-07-14Phase 1 Trial of PANtoTHEnic Acid in Patient With Metastatic or Unresectable Melanoma ON ImmunOtherapy (PANTHEON-IO)
-
CLINICAL_TRIALS study record update · 2025-07-08A Double-Blind, Randomized Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin
-
CLINICAL_TRIALS study record update · 2025-07-08A Randomized Study of the Efficacy and Safety of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) Versus Standard Adjuvant Therapy With Pembrolizumab in Patients With Resectable Stage III Skin Melanoma.
-
CLINICAL_TRIALS study record update · 2025-06-25FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)